{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:36:05Z","timestamp":1793644565884,"version":"4.5.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-70772-x","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T01:05:16Z","timestamp":1773968716000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Structural mechanism of substrate binding and inhibition of human taurine transporter"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6663-305X","authenticated-orcid":false,"given":"Yuhan","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duanning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1088-2299","authenticated-orcid":false,"given":"Jiameng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1405-6147","authenticated-orcid":false,"given":"Yue","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0612-3936","authenticated-orcid":false,"given":"Wenming","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1440-9275","authenticated-orcid":false,"given":"Luping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9851-0065","authenticated-orcid":false,"given":"Jing-Xiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"70772_CR1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.4062\/biomolther.2017.251","volume":"26","author":"S Schaffer","year":"2018","unstructured":"Schaffer, S. & Kim, H. W. Effects and mechanisms of taurine as a therapeutic agent. Biomol. Ther. 26, 225\u2013241 (2018).","journal-title":"Biomol. Ther."},{"key":"70772_CR2","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1138364","volume":"188","author":"KC Hayes","year":"1975","unstructured":"Hayes, K. C., Carey, R. E. & Schmidt, S. Y. Retinal degeneration associated with taurine deficiency in the cat. Science 188, 949\u2013951 (1975).","journal-title":"Science"},{"key":"70772_CR3","doi-asserted-by":"crossref","unstructured":"Qaradakhi, T. et al. The anti-inflammatory effect of taurine on cardiovascular disease. Nutrients 12, 2847 (2020).","DOI":"10.3390\/nu12092847"},{"key":"70772_CR4","doi-asserted-by":"publisher","first-page":"F497","DOI":"10.1136\/adc.2003.048389","volume":"89","author":"BA Wharton","year":"2004","unstructured":"Wharton, B. A., Morley, R., Isaacs, E. B., Cole, T. J. & Lucas, A. Low plasma taurine and later neurodevelopment. Arch. Dis. Child. Fetal Neonatal Ed. 89, F497\u2013498 (2004).","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"70772_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00726-012-1361-4","volume":"46","author":"J Marcinkiewicz","year":"2014","unstructured":"Marcinkiewicz, J. & Kontny, E. Taurine and inflammatory diseases. Amino Acids 46, 7\u201320 (2014).","journal-title":"Amino Acids"},{"key":"70772_CR6","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.3892\/mmr.2020.11321","volume":"22","author":"S Baliou","year":"2020","unstructured":"Baliou, S. et al. Significance of taurine transporter (TauT) in homeostasis and its layers of regulation (Review). Mol. Med. Rep. 22, 2163\u20132173 (2020).","journal-title":"Mol. Med. Rep."},{"key":"70772_CR7","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0076-6879(07)28025-5","volume":"428","author":"U Warskulat","year":"2007","unstructured":"Warskulat, U. et al. Phenotype of the taurine transporter knockout mouse. Methods Enzymol. 428, 439\u2013458 (2007).","journal-title":"Methods Enzymol."},{"key":"70772_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/1423-0127-17-S1-S20","volume":"17","author":"T Ito","year":"2010","unstructured":"Ito, T. et al. Cardiac and skeletal muscle abnormality in taurine transporter-knockout mice. J. Biomed. Sci. 17, S20 (2010).","journal-title":"J. Biomed. Sci."},{"key":"70772_CR9","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1093\/hmg\/ddz303","volume":"29","author":"M Ansar","year":"2020","unstructured":"Ansar, M. et al. Taurine treatment of retinal degeneration and cardiomyopathy in a consanguineous family with SLC6A6 taurine transporter deficiency. Hum. Mol. Genet. 29, 618\u2013623 (2020).","journal-title":"Hum. Mol. Genet."},{"key":"70772_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-017-0695-7","volume":"14","author":"YF Xia","year":"2017","unstructured":"Xia, Y. F. et al. miR-3156-3p is downregulated in HPV-positive cervical cancer and performs as a tumor-suppressive miRNA. Virol. J. 14, 20 (2017).","journal-title":"Virol. J."},{"key":"70772_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/srep04852","volume":"4","author":"M Yasunaga","year":"2014","unstructured":"Yasunaga, M. & Matsumura, Y. Role of SLC6A6 in promoting the survival and multidrug resistance of colorectal cancer. Sci. Rep. 4, 4852 (2014).","journal-title":"Sci. Rep."},{"key":"70772_CR12","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1016\/j.cell.2024.03.011","volume":"187","author":"T Cao","year":"2024","unstructured":"Cao, T. et al. Cancer SLC6A6-mediated taurine uptake transactivates immune checkpoint genes and induces exhaustion in CD8+ T cells. Cell 187, 2288\u20132304.e2227 (2024).","journal-title":"Cell"},{"key":"70772_CR13","doi-asserted-by":"crossref","unstructured":"Stary, D. & Bajda, M. Structural studies of the taurine transporter: a potential biological target from the GABA transporter subfamily in cancer therapy. Int. J. Mol. Sci. 25, 7339 (2024).","DOI":"10.3390\/ijms25137339"},{"key":"70772_CR14","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/978-981-13-8023-5_50","volume":"1155","author":"X Han","year":"2019","unstructured":"Han, X. Targeting taurine transporter (TauT) for cancer immunotherapy of p53 mutation mediated cancers - molecular basis and preclinical implication. Adv. Exp. Med. Biol. 1155, 543\u2013553 (2019).","journal-title":"Adv. Exp. Med. Biol."},{"key":"70772_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.mam.2012.07.002","volume":"34","author":"AB Pramod","year":"2013","unstructured":"Pramod, A. B., Foster, J., Carvelli, L. & Henry, L. K. SLC6 transporters: structure, function, regulation, disease association and therapeutics. Mol. Asp. Med. 34, 197\u2013219 (2013).","journal-title":"Mol. Asp. Med."},{"key":"70772_CR16","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1113\/JP271418","volume":"594","author":"JR Terrill","year":"2016","unstructured":"Terrill, J. R., Pinniger, G. J., Graves, J. A., Grounds, M. D. & Arthur, P. G. Increasing taurine intake and taurine synthesis improves skeletal muscle function in the mdx mouse model for Duchenne muscular dystrophy.  J. Physiol. 594, 3095\u20133110 (2016).","journal-title":"J. Physiol."},{"key":"70772_CR17","doi-asserted-by":"publisher","first-page":"62","DOI":"10.4103\/1673-5374.374139","volume":"19","author":"A Jangra","year":"2024","unstructured":"Jangra, A. et al. Emergence of taurine as a therapeutic agent for neurological disorders. Neural Regen. Res. 19, 62\u201368 (2024).","journal-title":"Neural Regen. Res."},{"key":"70772_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101223","volume":"24","author":"M Jakaria","year":"2019","unstructured":"Jakaria, M. et al. Taurine and its analogs in neurological disorders: Focus on therapeutic potential and molecular mechanisms. Redox Biol. 24, 101223 (2019).","journal-title":"Redox Biol."},{"key":"70772_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-0-387-75681-3_3","volume":"643","author":"TA Miyamoto","year":"2009","unstructured":"Miyamoto, T. A. et al. Taurine-mediated cardioprotection is greater when administered upon reperfusion than prior to ischemia. Adv. Exp. Med. Biol. 643, 27\u201336 (2009).","journal-title":"Adv. Exp. Med. Biol."},{"key":"70772_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3892\/etm.2015.2476","volume":"10","author":"S Tu","year":"2015","unstructured":"Tu, S. et al. Effect of taurine on the proliferation and apoptosis of human hepatocellular carcinoma HepG2 cells. Exp. Ther. Med. 10, 193\u2013200 (2015).","journal-title":"Exp. Ther. Med."},{"key":"70772_CR21","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.preteyeres.2014.03.001","volume":"41","author":"N Froger","year":"2014","unstructured":"Froger, N. et al. Taurine: The comeback of a neutraceutical in the prevention of retinal degenerations. Prog. Retinal Eye Res. 41, 44\u201363 (2014).","journal-title":"Prog. Retinal Eye Res."},{"key":"70772_CR22","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/j.1471-4159.1986.tb04519.x","volume":"47","author":"OM Larsson","year":"1986","unstructured":"Larsson, O. M., Griffiths, R., Allen, I. C. & Schousboe, A. Mutual inhibition kinetic analysis of gamma-aminobutyric acid, taurine, and beta-alanine high-affinity transport into neurons and astrocytes: evidence for similarity between the taurine and beta-alanine carriers in both cell types. J. Neurochem. 47, 426\u2013432 (1986).","journal-title":"J. Neurochem."},{"key":"70772_CR23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.pharep.2018.10.005","volume":"71","author":"M Richter","year":"2019","unstructured":"Richter, M., Moroniak, S. J. & Michel, H. Identification of competitive inhibitors of the human taurine transporter TauT in a human kidney cell line. Pharmacol. Rep. 71, 121\u2013129 (2019).","journal-title":"Pharmacol. Rep."},{"key":"70772_CR24","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1248\/bpb.b13-00991","volume":"37","author":"T Yahara","year":"2014","unstructured":"Yahara, T., Tachikawa, M., Akanuma, S. -i, Kubo, Y. & Hosoya, K. -i Amino acid residues involved in the substrate specificity of TauT\/SLC6A6 for taurine and \u03b3-aminobutyric acid. Biol. Pharm. Bull. 37, 817\u2013825 (2014).","journal-title":"Biol. Pharm. Bull."},{"key":"70772_CR25","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.str.2012.06.009","volume":"20","author":"M Hattori","year":"2012","unstructured":"Hattori, M., Hibbs, R. E. & Gouaux, E. A fluorescence-detection size-exclusion chromatography-based thermostability assay for membrane protein precrystallization screening. Structure 20, 1293\u20131299 (2012).","journal-title":"Structure"},{"key":"70772_CR26","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1038\/nprot.2014.173","volume":"9","author":"A Goehring","year":"2014","unstructured":"Goehring, A. et al. Screening and large-scale expression of membrane proteins in mammalian cells for structural studies. Nat. Protoc. 9, 2574\u20132585 (2014).","journal-title":"Nat. Protoc."},{"key":"70772_CR27","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nature03978","volume":"437","author":"A Yamashita","year":"2005","unstructured":"Yamashita, A., Singh, S. K., Kawate, T., Jin, Y. & Gouaux, E. Crystal structure of a bacterial homologue of Na+\/Cl-dependent neurotransmitter transporters. Nature 437, 215\u2013223 (2005).","journal-title":"Nature"},{"key":"70772_CR28","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/s41586-022-04814-x","volume":"606","author":"Z Motiwala","year":"2022","unstructured":"Motiwala, Z. et al. Structural basis of GABA reuptake inhibition. Nature 606, 820\u2013826 (2022).","journal-title":"Nature"},{"key":"70772_CR29","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1681\/ASN.V1091874","volume":"10","author":"X Han","year":"1999","unstructured":"Han, X., Budreau, A. M. & Chesney, R. W. Ser-322 is a critical site for PKC regulation of the MDCK cell taurine transporter (pNCT). J. Am. Soc. Nephrol. 10, 1874\u20131879 (1999).","journal-title":"J. Am. Soc. Nephrol."},{"key":"70772_CR30","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41594-019-0253-7","volume":"26","author":"MH Cheng","year":"2019","unstructured":"Cheng, M. H. & Bahar, I. Monoamine transporters: structure, intrinsic dynamics and allosteric regulation. Nat. Struct. Mol. Biol. 26, 545\u2013556 (2019).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"70772_CR31","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41586-024-07804-3","volume":"632","author":"JC Nielsen","year":"2024","unstructured":"Nielsen, J. C. et al. Structure of the human dopamine transporter in complex with cocaine. Nature 632, 678\u2013685 (2024).","journal-title":"Nature"},{"key":"70772_CR32","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/s41594-023-01011-w","volume":"30","author":"SR Nayak","year":"2023","unstructured":"Nayak, S. R. et al. Cryo-EM structure of GABA transporter 1 reveals substrate recognition and transport mechanism. Nat. Struct. Mol. Biol. 30, 1023\u20131032 (2023).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"70772_CR33","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41586-024-07810-5","volume":"633","author":"W Ji","year":"2024","unstructured":"Ji, W. et al. Substrate binding and inhibition mechanism of norepinephrine transporter. Nature 633, 473\u2013479 (2024).","journal-title":"Nature"},{"key":"70772_CR34","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/s41586-024-07796-0","volume":"632","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. Dopamine reuptake and inhibitory mechanisms in human dopamine transporter. Nature 632, 686\u2013694 (2024).","journal-title":"Nature"},{"key":"70772_CR35","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/s41594-023-00983-z","volume":"30","author":"A Zhu","year":"2023","unstructured":"Zhu, A. et al. Molecular basis for substrate recognition and transport of human GABA transporter GAT1. Nat. Struct. Mol. Biol. 30, 1012\u20131022 (2023).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"70772_CR36","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/nsmb.2894","volume":"21","author":"L Malinauskaite","year":"2014","unstructured":"Malinauskaite, L. et al. A mechanism for intracellular release of Na+ by neurotransmitter\/sodium symporters. Nat. Struct. Mol. Biol. 21, 1006\u20131012 (2014).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"70772_CR37","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1113\/jphysiol.2008.164228","volume":"587","author":"CM Anderson","year":"2009","unstructured":"Anderson, C. M., Howard, A., Walters, J. R., Ganapathy, V. & Thwaites, D. T. Taurine uptake across the human intestinal brush-border membrane is via two transporters: H+-coupled PAT1 (SLC36A1) and Na+- and Cl(-)-dependent TauT (SLC6A6).  J. Physiol. 587, 731\u2013744 (2009).","journal-title":"J. Physiol."},{"key":"70772_CR38","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/j.cell.2024.02.026","volume":"187","author":"Y Wei","year":"2024","unstructured":"Wei, Y. et al. Transport mechanism and pharmacology of the human GlyT1. Cell 187, 1719\u20131732.e1714 (2024).","journal-title":"Cell"},{"key":"70772_CR39","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/s41422-024-01024-0","volume":"34","author":"A Song","year":"2024","unstructured":"Song, A. & Wu, X. Mechanistic insights of substrate transport and inhibitor binding revealed by high-resolution structures of human norepinephrine transporter. Cell Res. 34, 810\u2013813 (2024).","journal-title":"Cell Res."},{"key":"70772_CR40","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/s41586-024-07638-z","volume":"632","author":"T Hu","year":"2024","unstructured":"Hu, T. et al. Transport and inhibition mechanisms of the human noradrenaline transporter. Nature 632, 930\u2013937 (2024).","journal-title":"Nature"},{"key":"70772_CR41","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/BF00967969","volume":"11","author":"I Holopainen","year":"1986","unstructured":"Holopainen, I. & Kontro, P. High-affinity uptake of taurine and beta-alanine in primary cultures of rat astrocytes. Neurochem. Res. 11, 207\u2013215 (1986).","journal-title":"Neurochem. Res."},{"key":"70772_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59066-w","volume":"16","author":"R Yadav","year":"2025","unstructured":"Yadav, R., Han, G. W. & Gati, C. Molecular basis of human GABA transporter 3 inhibition. Nat. Commun. 16, 3830 (2025).","journal-title":"Nat. Commun."},{"key":"70772_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57613-z","volume":"16","author":"N Li","year":"2025","unstructured":"Li, N. et al. Modulation of the human GlyT1 by clinical drugs and cholesterol. Nat. Commun. 16, 2412 (2025).","journal-title":"Nat. Commun."},{"key":"70772_CR44","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature10737","volume":"481","author":"H Krishnamurthy","year":"2012","unstructured":"Krishnamurthy, H. & Gouaux, E. X-ray structures of LeuT in substrate-free outward-open and apo inward-open states. Nature 481, 469\u2013474 (2012).","journal-title":"Nature"},{"key":"70772_CR45","doi-asserted-by":"publisher","first-page":"eabl3857","DOI":"10.1126\/sciadv.abl3857","volume":"7","author":"D Yang","year":"2021","unstructured":"Yang, D. & Gouaux, E. Illumination of serotonin transporter mechanism and role of the allosteric site. Sci. Adv. 7, eabl3857 (2021).","journal-title":"Sci. Adv."},{"key":"70772_CR46","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/j.bpj.2015.02.010","volume":"108","author":"J Grouleff","year":"2015","unstructured":"Grouleff, J., S\u00f8ndergaard, S., Kolds\u00f8, H. & Schi\u00f8tt, B. Properties of an inward-facing state of LeuT: conformational stability and substrate release. Biophys. J. 108, 1390\u20131399 (2015).","journal-title":"Biophys. J."},{"key":"70772_CR47","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00018-024-05309-w","volume":"81","author":"M Bhatt","year":"2024","unstructured":"Bhatt, M. et al. Unveiling the crucial role of betaine: modulation of GABA homeostasis via SLC6A1 transporter (GAT1). Cell. Mol. Life Sci. 81, 269 (2024).","journal-title":"Cell. Mol. Life Sci."},{"key":"70772_CR48","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/S0022-3565(24)39309-7","volume":"293","author":"P Scholze","year":"2000","unstructured":"Scholze, P. et al. Transporter-mediated release: a superfusion study on human embryonic kidney cells stably expressing the human serotonin transporter. J. Pharm. Exp. Ther. 293, 870\u2013878 (2000).","journal-title":"J. Pharm. Exp. Ther."},{"key":"70772_CR49","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/s41586-021-03274-z","volume":"591","author":"A Shahsavar","year":"2021","unstructured":"Shahsavar, A. et al. Structural insights into the inhibition of glycine reuptake. Nature 591, 677\u2013681 (2021).","journal-title":"Nature"},{"key":"70772_CR50","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.bbrc.2022.01.056","volume":"594","author":"W Guo","year":"2022","unstructured":"Guo, W., Wang, M. & Chen, L. A co-expression vector for baculovirus-mediated protein expression in mammalian cells. Biochem. Biophys. Res. Commun. 594, 69\u201373 (2022).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"70772_CR51","doi-asserted-by":"crossref","unstructured":"Song, K. et al. Structural basis for human TRPC5 channel inhibition by two distinct inhibitors. eLife 10, e63429 (2021).","DOI":"10.7554\/eLife.63429"},{"key":"70772_CR52","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nmeth.4193","volume":"14","author":"SQ Zheng","year":"2017","unstructured":"Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331\u2013332 (2017).","journal-title":"Nat. Methods"},{"key":"70772_CR53","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"70772_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsb.2015.11.003","volume":"193","author":"K Zhang","year":"2016","unstructured":"Zhang, K. Gctf: Real-time CTF determination and correction. J. Struct. Biol. 193, 1\u201312 (2016).","journal-title":"J. Struct. Biol."},{"key":"70772_CR55","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/s41592-019-0575-8","volume":"16","author":"T Bepler","year":"2019","unstructured":"Bepler, T. et al. Positive-unlabeled convolutional neural networks for particle picking in cryo-electron micrographs. Nat. Methods 16, 1153\u20131160 (2019).","journal-title":"Nat. Methods"},{"key":"70772_CR56","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.cell.2020.11.043","volume":"184","author":"N Wang","year":"2021","unstructured":"Wang, N. et al. Structural basis of human monocarboxylate transporter 1 inhibition by anti-cancer drug candidates. Cell 184, 370\u2013383.e313 (2021).","journal-title":"Cell"},{"key":"70772_CR57","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/s41592-020-00990-8","volume":"17","author":"A Punjani","year":"2020","unstructured":"Punjani, A., Zhang, H. & Fleet, D. J. Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction. Nat. Methods 17, 1214\u20131221 (2020).","journal-title":"Nat. Methods"},{"key":"70772_CR58","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493\u2013500 (2024).","journal-title":"Nature"},{"key":"70772_CR59","doi-asserted-by":"crossref","unstructured":"Meng, E. C. et al. UCSF ChimeraX: tools for structure building and analysis. Protein Sci. 32, e4792 (2023).","DOI":"10.1002\/pro.4792"},{"key":"70772_CR60","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. Sect. D. Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. Sect. D. Biol. Crystallogr."},{"key":"70772_CR61","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1107\/S2059798318006551","volume":"74","author":"PV Afonine","year":"2018","unstructured":"Afonine, P. V. et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr. Sect. D. Struct. Biol. 74, 531\u2013544 (2018).","journal-title":"Acta Crystallogr. Sect. D. Struct. Biol."},{"key":"70772_CR62","unstructured":"DeLano, W. L. Pymol: An open-source molecular graphics tool. CCP4 Newsl. Protein Crystallogr. 40, 82\u201392 (2002)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70772-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70772-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70772-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:03:38Z","timestamp":1778760218000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70772-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["70772"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-70772-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]},"assertion":[{"value":"20 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4257"}}